on invasive visualization of biologic and topographic changes in (sub-)cutaneous melanoma metastases induced by antitumoral treatment

• Conditions: C43.9; C79.2; Malignant melanoma of skin, unspecified; Secondary malignant neoplasm of skin

• Registration Number: DRKS00017175
• Lead Sponsor: niversitätsklinik EssenKlinik für Dermatologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-05-16
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

patients with (sub-)cutaneous melanoma metastases

- age =18 years

Exclusion Criteria

- age < 18 years

- pregnancy

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quantification in decrease of optical density (induced by reduction of melanin containing cells) before (, during) and after melanoma Treatment. The optical density (OD) will comparatively be quantified in the MSOT.

Secondary Outcome Measures

Name	Time	Method
Quantification of vessel density in cutaneous metastasis before (, during) and after melanoma treatment. The number and size of vessels will comparatively be quantified in the MSOT.